Biosecurity

How Will the Biosecure Act Transform the Biotech Industry's Future?
Biotech & Bioprocessing How Will the Biosecure Act Transform the Biotech Industry's Future?

The Biosecure Act, proposed by the U.S. government last year, aims to safeguard national security by regulating how genetic and biological data are handled, specifically targeting entities linked to adversarial governments like China. With a focus on preventing U.S. federal agencies from engaging

WuXi AppTec Faces Revenue Decline Amid BIOSECURE Act Concerns
Biotech & Bioprocessing WuXi AppTec Faces Revenue Decline Amid BIOSECURE Act Concerns

In a significant development affecting the biotech industry, WuXi AppTec, a leading Chinese manufacturing company, has reported a revenue decline for the first half of 2024. This downward trend coincides with growing concerns about the impending BIOSECURE Act, which aims to restrict U.S.

Is the BIOSECURE Act the Answer to U.S. Biopharma Security Concerns?
Biotech & Bioprocessing Is the BIOSECURE Act the Answer to U.S. Biopharma Security Concerns?

The biopharma sector is at an inflection point as the United States grapples with concerns about China's influence and potential risks posed by collaborations with Chinese military medical institutions. A legislative measure known as the BIOSECURE Act aims to address these apprehensions,

Will the BIOSECURE Act Reshape U.S. Biopharma's Ties with China?
Biotech & Bioprocessing Will the BIOSECURE Act Reshape U.S. Biopharma's Ties with China?

The introduction of the BIOSECURE Act marks a significant moment in U.S. legislative history, specifically targeting the intersection of national security and biotechnology. This proposed legislation aims to halt federal contracts with Chinese biotech firms, citing potential national security

How Will the BIOSECURE Act Reshape U.S.-China Biopharma Partnerships?
Biotech & Bioprocessing How Will the BIOSECURE Act Reshape U.S.-China Biopharma Partnerships?

The proposed BIOSECURE Act stands poised to significantly alter the landscape of U.S.-China biopharma partnerships by addressing national security concerns through restrictive measures. Specifically, the act aims to block certain Chinese biotech equipment and service providers from the U.S. market.

Is the CCP Influencing US Biotech Through GenScript?
Biotech & Bioprocessing Is the CCP Influencing US Biotech Through GenScript?

Recent actions by U.S. House lawmakers have cast a spotlight on GenScript, a Chinese Contract Development and Manufacturing Organization (CDMO), and its cell therapy division, Legend Biotech, amidst concerns of potential Chinese Communist Party (CCP) influence within the American biotech realm.

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later